Lutrelef 3,2 mg, Injektionspräparat

7680473660388 CH-47366 Injektionspräparat
Lutrelef 3,2 mg, Injektionspräparat
Lutrelef 3,2 mg, Injektionspräparat
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionspräparat
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
28/07/2022
Summary of Product Characteristics
Français
28/07/2022
Summary of Product Characteristics
Italien
28/07/2022

Detailed composition

Substance Quantity Type Category
natrii chloridum
- Substance HNIDK
gonadorelini acetas
3.2 MG Substance WIZUS
natrium
35.4 MG Substance HBESI
gonadorelinum
2.91 MG Substance Wirkstoff (Principe actif)
acidum hydrochloridum
- Substance HNIDK
mannitolum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
10.0 ML Substance HNIDK

Authorization holder

Ferring AG

6340 Baar

Authorization information

Swissmedic authorization number
47366
Drug name
Lutrelef, Injektionspräparat
Galenic form
PULMJ
ATC Code
H01CA01
Authorization status
Z
Dispensing category
B
First authorization
04/08/1986
Authorization expiration date
31/12/9999
IT Number
07.03.1.
Domain
Human medicine
Field of application
Hypothalamische Amenorrhoe, zentraler Hypogonadismus beim Mann

Package details

Description (FR)
LUTRELEF subst sèche 3.2 mg c solv flac
Description (DE)
LUTRELEF Trockensub 3.2 mg c Solv Durchstf
Market launch
04/08/1986
Narcotic (BTM)
No

Other package sizes (1)

LUTRELEF 0.8 sol inj 0.8 mg c solv 10ml fiole
1 DUR
GTIN: 7680473660111
Not in V1
Buy us a coffee Explore the data